Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using Two Related Donors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01532635
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:50.801245+00:00
Published At
2014-11-10T00:00:00+00:00
Record Updated At
2025-05-04
Results Posted At
2014-11-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hematologic Malignancy", "Leukemia", "Acute Lymphoblastic Leukemia", "ALL", "Acute Myelogenous Leukemia", "AML", "Chronic Lymphocytic Leukemia", "CLL", "Lymphoma", "Hodgkin\u0027s Lymphoma", "Non-hodgkin\u0027s Lymphoma", "Myeloma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-04"
protocolSection.identificationModule.nctId
"NCT01532635"
protocolSection.identificationModule.officialTitle
"A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using Two Related Donors"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-11-10"

Study condition terms

  • Hematologic Malignancy (protocolSection.conditionsModule.conditions)
  • Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • ALL (protocolSection.conditionsModule.conditions)
  • Acute Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • AML (protocolSection.conditionsModule.conditions)
  • Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • CLL (protocolSection.conditionsModule.conditions)
  • Lymphoma (protocolSection.conditionsModule.conditions)
  • Hodgkin's Lymphoma (protocolSection.conditionsModule.conditions)
  • Non-hodgkin's Lymphoma (protocolSection.conditionsModule.conditions)
  • Myeloma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.